The Europe veterinary 3D printing market size is anticipated to reach USD 73.9 million by 2030, registering a CAGR of 10.2% from 2025 to 2030. One of the most dynamic emerging factors affecting the market is the emerging usage of 3D printing in developing veterinary drugs. Although still in the research stage, the application of this technology is being actively studied by many researchers worldwide.
According to an article in Pharma Excipients, 3D printing is being explored to create tailored veterinary drugs, addressing the limitations of traditional one-size-fits-all medications for animals. A joint-collaboration between researchers from around the globe, a research study is focusing on developing a once-daily, dual-release tablet for cats and dogs using semi-solid extrusion (SSE) 3D printing, specifically for Metoclopramide (MCP), a common anti-nausea drug. The dual-release system aims to provide both rapid onset and sustained action, reducing the frequency of administration needed due to MCP's short half-life. They successfully created different-sized tablets with tailored doses, demonstrating a strong correlation between the design and drug amount. These tablets contained cellulosic polymers to control drug release, with dissolution studies showing the impact of polymer combinations and tablet surface area on release profiles.
SSE 3D printing allows for precise dosing and customization of release profiles by altering tablet structures and geometries. The technology is suitable for thermo-sensitive ingredients and minimizes contamination risk compared to traditional methods. Including liver powder in the immediate-release formulation enhances palatability, making the tablets more pet-friendly. This approach offers the potential to revolutionize veterinary medicine by providing customized treatments, improving patient compliance, and optimizing treatment outcomes. The study highlights the practical use of SSE 3D printing in developing precise and pet-friendly tailored tablets, offering enhanced treatment options for small animals close to the point of care.
The use of 3D printing in veterinary medicine has the potential to enable precision in drug formulations and address the unique needs of each animal, overcoming the limitations of standardized medications. It has the potential to provide on-demand production of customized dosages close to the point of care, improving treatment accuracy and reducing preparation errors. Integrating innovative drug delivery systems like dual-release tablets can optimize therapeutic outcomes while minimizing dosing frequency. 3D printing can revolutionize veterinary pharmacology by providing flexible, efficient, and patient-specific solutions.
This product will be delivered within 1-3 business days.
According to an article in Pharma Excipients, 3D printing is being explored to create tailored veterinary drugs, addressing the limitations of traditional one-size-fits-all medications for animals. A joint-collaboration between researchers from around the globe, a research study is focusing on developing a once-daily, dual-release tablet for cats and dogs using semi-solid extrusion (SSE) 3D printing, specifically for Metoclopramide (MCP), a common anti-nausea drug. The dual-release system aims to provide both rapid onset and sustained action, reducing the frequency of administration needed due to MCP's short half-life. They successfully created different-sized tablets with tailored doses, demonstrating a strong correlation between the design and drug amount. These tablets contained cellulosic polymers to control drug release, with dissolution studies showing the impact of polymer combinations and tablet surface area on release profiles.
SSE 3D printing allows for precise dosing and customization of release profiles by altering tablet structures and geometries. The technology is suitable for thermo-sensitive ingredients and minimizes contamination risk compared to traditional methods. Including liver powder in the immediate-release formulation enhances palatability, making the tablets more pet-friendly. This approach offers the potential to revolutionize veterinary medicine by providing customized treatments, improving patient compliance, and optimizing treatment outcomes. The study highlights the practical use of SSE 3D printing in developing precise and pet-friendly tailored tablets, offering enhanced treatment options for small animals close to the point of care.
The use of 3D printing in veterinary medicine has the potential to enable precision in drug formulations and address the unique needs of each animal, overcoming the limitations of standardized medications. It has the potential to provide on-demand production of customized dosages close to the point of care, improving treatment accuracy and reducing preparation errors. Integrating innovative drug delivery systems like dual-release tablets can optimize therapeutic outcomes while minimizing dosing frequency. 3D printing can revolutionize veterinary pharmacology by providing flexible, efficient, and patient-specific solutions.
Europe Veterinary 3D Printing Market Report Highlights
- Based on product, the implants segment held the highest market share of 31.96% in 2024. This segment includes 3D-printed veterinary implants such as TPLO and TPLA, which are increasingly popular due to their ability to be customized for diverse animal anatomies, improving surgical precision and outcomes.
- The other animal segment, encompassing animals such as horses, turtles, birds, and livestock, is expected to grow at a CAGR exceeding 12% during the forecast period. This rapid expansion is driven by the increasing use of 3D printing to treat various conditions and the emergence of specialized companies that develop 3D-printed products tailored to specific species.
- Based on application, the surgical planning segment is projected to experience the fastest CAGR during the forecast period, due to the benefits of 3D printing. This technology allows for creating patient-specific anatomical models, enhances the visualization of complex structures, and enables customized surgical instruments and guides. Veterinarians can thoroughly study fractures or deformities, pre-contour implants, and rehearse surgical steps, reducing complications and improving outcomes.
- The UK held the largest market share of more than 24% in 2024. The country's dominance can be attributed to factors such as the active involvement of veterinary practices in utilizing 3D printing technology to help resolve animal health problems and researchers fostering an innovative spirit to help improve upon the existing products.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This Report Addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Veterinary 3D Printing Market Variable Trends & Scope
Chapter 4. Veterinary 3D Printing Market: Product Estimates & Trend Analysis
Chapter 5. Veterinary 3D Printing Market: Animal Estimates & Trend Analysis
Chapter 6. Veterinary 3D Printing Market: Application Estimates & Trend Analysis
Chapter 7. Veterinary 3D Printing Market: Material Estimates & Trend Analysis
Chapter 8. Veterinary 3D Printing Market: End Use Estimates & Trend Analysis
Chapter 9. Veterinary 3D Printing Market: Country Estimates & Trend Analysis, by product, animal, applications, materials, & end use
Chapter 10. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- bio3Dvet
- WIMBA
- Vimian
- 3D Systems Inc.
- OrthoDesigns
- Ortho Vet 3D
- r3volutionD AG
- CABIOMEDE Vet
- Vet 3D
- Materialise
- Formlabs
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 154 |
| Published | March 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 41.3 Million |
| Forecasted Market Value ( USD | $ 73.9 Million |
| Compound Annual Growth Rate | 10.2% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 11 |
